The CX 2017 Peripheral Arterial Consensus Update Programme will focus on PATHWAYS OF CARE – whether to intervene, when and at what threshold, method and follow-up.
“Over three days (25–27 April) there will be a comprehensive coverage of the most important aspects of peripheral arterial intervention as well as some important new trial evidence being presented and discussed,” says Andrew Holden, member of the CX Programme Organising Board.
Key topics include:
Should endovascular treatment be the first option rather than exercise for claudicants?
What is driving the shift towards endovascular for acute ischaemia?
What are the guidelines for superficial femoral artery intervention?
What are the current guidelines for drug-coated balloon (DCB) use?
Does “endovascular first practice” alter equipoise for below-the-knee trials?
Is the angiosome concept codswallop?
How important is speed of revascularisation in the diabetic foot?
As well as first-time presentations on:
Podium 1st: 12-month outcomes of standard vs. wider usage of drug-coated balloon – IN.PACT global study
Podium 1st: Outcomes of drug-coated balloon with calcification, >15cm, complete total occlusion and TASC C and D lesions – IN.PACT study
Late breaking: Downstream coating effects of various drug-coated balloons
First-in-man: Randomised trial of drug-coated balloon vs. POBA – 12-month data (RANGER-SFA)
Podium 1st: BIOFLEX PEACE – 12-month results of a self-expanding flexible stent in long femoropopliteal lesions
Podium 1st: BIOLUX 4EVER – drug-coated balloon and stent in the SFA
The CX Peripheral Arterial Consensus update will take place at the Charing Cross Symposium on Tuesday 25 April – Upper Main Auditorium, Olympia Grand, London, UK
Click here to access the CX Interactive Plenary Programme – Peripheral Arterial Consensus
Click here to access the CX Interactive Plenary Programme – ilegx Interdisciplinary Consensus on Severe Ischaemia
Click here to access the CX Interactive Parallel Sessions Programme – Peripheral Arterial Abstracts
Click here to register